Marijuana and Beer: How Hexo Corp. (TSX:HEXO) and Molson Coors Canada Inc. (TSX:TPX.B) Are the Perfect Couple

When cannabis products become legally permissible in Canada this year, Hexo Corp. (TSX:HEXO) and Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) are expected to assume joint leadership of the new market.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Investors in the cannabis industry are getting used to the falling prices of weed stocks. While the buying opportunity is there, the impetus to purchase is absent due to the headwinds the sector is facing. The apprehension is widespread that no stock stands out to actually present a significant upside in the near future.

But among all the weed stocks, it is Hexo (TSX:HEXO) that has the potential to outperform and earn the first-mover advantage. However, investors should also consider beer maker Molson Coors Canada (TSX:TPX.B)(NYSE:TAP) in tandem with the former to form a formidable stock combo.

Hexo is gaining strength

Hexo has gone through extreme highs and lows much like industry peers but has returned to the high level of $9 last month. On a year-to-date basis, the stock is now up now +91.3%. March was a relatively strong month, and starting the second quarter with a +2.04% gain to $9.01 means an auspicious performance lies ahead.

Prospective investors in this space would probably pick the stock for price consideration. Hexo is significantly cheaper when compared to Canopy Growth, Cronos Group, and Aurora Cannabis.

Production wise, Hexo’s capacity might not be too far off from the bigger rivals. The company also has the lowest wage rates, which translate to lower production costs. But a solid advantage is the supply arrangement with the Quebec Cannabis authority. The next big move is venturing into new and lucrative product areas. 

Enter Molson Coors

People should keep in mind that Hexo has a joint venture with Molson Coors. Truss, the standalone company formed out of the collaboration, is about to come into the picture. It will be the money spinner for both stocks.

The non-alcoholic, cannabis-infused beverage market is expected to be huge in Canada. Sometime this year, consumable cannabis could be legalized. Once it happens, the fusion of Canada’s leading brewer with the cannabis sector’s innovator will result to steady cash flow.

Molson Coors owns 57.5% of the joint venture with Hexo. The company knows that the marijuana market will affect the sales of alcohol makers. Thus, the move is a fallback in case beer sales continue to decline. There is no choice but to fast track the development and production of non-alcoholic, cannabis-infused beverages.

Pending the sale of cannabis-infused beverages, Molson Coors is making headlines. The low-calorie and low-carb Molson 67 beer will be introduced in the U.S. market. The digital and social media promotional campaigns are in full swing. Molson expects a wider acceptance of this unique, refreshing, and flavourful beer.

Market leaders in the new market

Molson Coors is up +6.63% year to date, but the stock is not as heavily traded as Hexo. However, there’s so much room to grow for North America’s second-largest beer maker and Hexo. Many might not agree with the fearless forecast that this partnership will assume market leadership in the new market., but it is very feasible.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »